Cellectar Biosciences Scheduled to Report Q3 2026 Earnings
Cellectar Biosciences (CLRB) is set to release its third-quarter earnings results on Tuesday, November 10th, prior to the market opening. Investors are closely watching for performance metrics as the company prepares to report its latest financial standing. The consensus earnings per share (EPS) estimate currently stands at -$0.56, which represents a significant year-over-year improvement of 60.3%. Historically, Cellectar Biosciences has demonstrated volatility in meeting expectations, having beaten EPS estimates in 50% of the reports over the past year.
Topics: earnings release EPS estimates